High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit
- PMID: 23522897
- PMCID: PMC3729120
- DOI: 10.2450/2013.0043-13
High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit
Figures
Comment on
-
Supportive treatment of severe anaemia in a Jehovah's Witness with severe trauma.Blood Transfus. 2013 Jul;11(3):452-3. doi: 10.2450/2013.0263-12. Epub 2013 Mar 19. Blood Transfus. 2013. PMID: 23522898 Free PMC article. No abstract available.
Similar articles
-
Supportive treatment of severe anaemia in a Jehovah's Witness with severe trauma.Blood Transfus. 2013 Jul;11(3):452-3. doi: 10.2450/2013.0263-12. Epub 2013 Mar 19. Blood Transfus. 2013. PMID: 23522898 Free PMC article. No abstract available.
-
Intravenous iron administration together with parenteral nutrition to very preterm Jehovah's Witness twins.BMJ Case Rep. 2014 Jun 2;2014:bcr2013202167. doi: 10.1136/bcr-2013-202167. BMJ Case Rep. 2014. PMID: 24891477 Free PMC article.
-
Mortality risk stratification in severely anaemic Jehovah's Witness patients.Intern Med J. 2012 Mar;42(3):e1-3. doi: 10.1111/j.1445-5994.2011.02699.x. Intern Med J. 2012. PMID: 22432994
-
The contemporary approach to the care of Jehovah's witnesses.J Trauma. 2008 Jul;65(1):237-47. doi: 10.1097/TA.0b013e318176cc66. J Trauma. 2008. PMID: 18580506 Review.
-
Treatment of anaemia in the polytrauma Jehovah's Witness.Ir Med J. 2003 Jan;96(1):8-10. Ir Med J. 2003. PMID: 12617434 Review.
Cited by
-
Hemoglobin-Based Oxygen Carrier for Traumatic Hemorrhagic Shock Treatment in a Jehovah's Witness.Arch Trauma Res. 2016 Feb 2;5(2):e30610. doi: 10.5812/atr.30610. eCollection 2016 Jun. Arch Trauma Res. 2016. PMID: 27679789 Free PMC article.
-
Successful Treatment of Severe Anemia using Erythropoietin in a Jehovah Witness with Non-Hodgkin Lymphoma.Hematol Rep. 2014 Dec 4;6(4):5600. doi: 10.4081/hr.2014.5600. eCollection 2014 Nov 19. Hematol Rep. 2014. PMID: 25568760 Free PMC article.
-
Cost-equivalence and Pluralism in Publicly-funded Health-care Systems.Health Care Anal. 2018 Dec;26(4):287-309. doi: 10.1007/s10728-016-0337-z. Health Care Anal. 2018. PMID: 28062971 Free PMC article.
References
-
- Tobian AAR, Ness PM, Noveck H, Carson JL. Time course and etiology of death in patients with severe anemia. Transfusion. 2009;49:1395–9. - PubMed
-
- Beliaev AM, Marshall RJ, Gordon M, et al. Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang. 2012;103:18–24. - PubMed
-
- Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42:812–8. - PubMed
-
- Beliaev AM, Marshall RJ, Smith W, Windsor JA. Treatment monitoring and mortality risk adjustment in anaemic Jehovah’s Witnesses. ANZ J Surg. 2013;83:161–4. - PubMed
-
- Beliaev AM, Marshall RJ, Smith W, Windsor JA. Mortality Risk Stratification in Severely Anaemic Jehovah’s Witness Patients. Intern Med J. 2012;42:e1–3. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical